| Year |
Citation |
Score |
| 2010 |
Skeiky YA, Dietrich J, Lasco TM, Stagliano K, Dheenadhayalan V, Goetz MA, Cantarero L, Basaraba RJ, Bang P, Kromann I, McMclain JB, Sadoff JC, Andersen P. Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen. Vaccine. 28: 1084-93. PMID 19896449 DOI: 10.1016/J.Vaccine.2009.10.114 |
0.535 |
|
| 2007 |
Yamamoto T, Lasco TM, Uchida K, Goto Y, Jeevan A, McFarland C, Ly L, Yamamoto S, McMurray DN. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs. Tuberculosis (Edinburgh, Scotland). 87: 155-65. PMID 17289434 DOI: 10.1016/J.Tube.2006.07.002 |
0.666 |
|
| 2006 |
Jeevan A, McFarland CT, Yoshimura T, Skwor T, Cho H, Lasco T, McMurray DN. Production and characterization of guinea pig recombinant gamma interferon and its effect on macrophage activation Infection and Immunity. 74: 213-224. PMID 16368975 DOI: 10.1128/Iai.74.1.213-224.2006 |
0.655 |
|
| 2005 |
McMurray DN, Allen SS, Jeevan A, Lasco T, Cho H, Skwor T, Yamamoto T, McFarland C, Yoshimura T. Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis Tuberculosis. 85: 295-301. PMID 16253558 DOI: 10.1016/J.Tube.2005.08.012 |
0.662 |
|
| 2005 |
Lasco TM, Cassone L, Kamohara H, Yoshimura T, McMurray DN. Evaluating the role of tumor necrosis factor-alpha in experimental pulmonary tuberculosis in the guinea pig. Tuberculosis (Edinburgh, Scotland). 85: 245-58. PMID 15958260 DOI: 10.1016/J.Tube.2005.01.001 |
0.62 |
|
| 2005 |
Cho H, Lasco TM, Allen SS, Yoshimura T, McMurray DN. Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages. Infection and Immunity. 73: 1367-76. PMID 15731034 DOI: 10.1128/Iai.73.3.1367-1376.2005 |
0.602 |
|
| 2005 |
Izzo A, Brandt L, Lasco T, Kipnis AP, Orme I. NIH pre-clinical screening program: overview and current status. Tuberculosis (Edinburgh, Scotland). 85: 25-8. PMID 15687024 DOI: 10.1016/J.Tube.2004.09.008 |
0.468 |
|
| 2004 |
Brandt L, Skeiky YA, Alderson MR, Lobet Y, Dalemans W, Turner OC, Basaraba RJ, Izzo AA, Lasco TM, Chapman PL, Reed SG, Orme IM. The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs. Infection and Immunity. 72: 6622-32. PMID 15501795 DOI: 10.1128/Iai.72.11.6622-6632.2004 |
0.529 |
|
| 2004 |
Allen SS, Cassone L, Lasco TM, McMurray DN. Effect of neutralizing transforming growth factor beta1 on the immune response against Mycobacterium tuberculosis in guinea pigs. Infection and Immunity. 72: 1358-63. PMID 14977939 DOI: 10.1128/Iai.72.3.1358-1363.2004 |
0.558 |
|
| 2004 |
Lasco TM, Turner OC, Cassone L, Sugawara I, Yamada H, McMurray DN, Orme IM. Rapid accumulation of eosinophils in lung lesions in guinea pigs infected with Mycobacterium tuberculosis. Infection and Immunity. 72: 1147-9. PMID 14742563 DOI: 10.1128/Iai.72.2.1147-1149.2004 |
0.567 |
|
| 2003 |
Lasco TM, Yamamoto T, Yoshimura T, Allen SS, Cassone L, McMurray DN. Effect of Mycobacterium bovis BCG vaccination on Mycobacterium-specific cellular proliferation and tumor necrosis factor alpha production from distinct guinea pig leukocyte populations. Infection and Immunity. 71: 7035-42. PMID 14638793 DOI: 10.1128/Iai.71.12.7035-7042.2003 |
0.66 |
|
| 2002 |
Brennan PJ, Terwilliger T, Barry CE, Manca C, Su H, Reed M, Rutter K, Domenech P, Kaplan G, Li YJ, Wagner D, Bermudez LE, Bodnar K, Flynn J, Campos-Neto A, ... ... Lasco TM, et al. The US-Japan Cooperative Medical Science Program Tuberculosis and Leprosy Panel's 36th annual research conference, New Orleans, Louisiana, USA, 15-17 July 2001 Tuberculosis. 82: 113-135. PMID 12408170 DOI: 10.1054/Tube.2002.0329 |
0.491 |
|
| Show low-probability matches. |